{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:16:27Z","timestamp":1786986987430,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI 117943"],"award-info":[{"award-number":["P30 AI 117943"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16 FTF 31200010"],"award-info":[{"award-number":["16 FTF 31200010"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.cjca.2018.11.029","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T12:55:43Z","timestamp":1543928143000},"page":"270-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Coronary Artery Disease Manifestations in HIV: What, How, and Why"],"prefix":"10.1016","volume":"35","author":[{"given":"Arjun","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Feinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2018.11.029_bib1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0b013e32835cae9c","article-title":"Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population","volume":"27","author":"Rodger","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.cjca.2018.11.029_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cjca.2018.11.029_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.amjcard.2015.10.030","article-title":"Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013","volume":"117","author":"Feinstein","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2018.11.029_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/COH.0000000000000039","article-title":"The global north: HIV epidemiology in high-income countries","volume":"9","author":"Sullivan","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.cjca.2018.11.029_bib5","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cjca.2018.11.029_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0b013e31821d33a5","article-title":"Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Quebec's public health insurance database","volume":"57","author":"Durand","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cjca.2018.11.029_bib7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2018.11.029_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MCA.0000000000000450","article-title":"Acute coronary syndromes in patients with HIV","volume":"28","author":"Seecheran","year":"2017","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.cjca.2018.11.029_bib9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s40618-017-0812-x","article-title":"Endocrinological aspects of HIV infection","volume":"41","author":"Mirza","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.cjca.2018.11.029_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11904-018-0411-2","article-title":"Inflammation and metabolic complications in HIV","volume":"15","author":"Bourgi","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.cjca.2018.11.029_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cyto.2012.01.013","article-title":"Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy","volume":"58","author":"Veloso","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.cjca.2018.11.029_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cit652","article-title":"Veterans Aging Cohort Study (VAC) Project Team. Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans","volume":"58","author":"Armah","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2018.11.029_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/HYPERTENSIONAHA.118.10893","article-title":"Hypertension in HIV-infected adults: novel pathophysiologic mechanisms","volume":"72","author":"Fahme","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2018.11.029_bib14","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.289.22.2978","article-title":"Impact of HIV infection and HAART on serum lipids in men","volume":"289","author":"Riddler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2018.11.029_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/135965350801300215","article-title":"Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial","volume":"13","author":"Phillips","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cjca.2018.11.029_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M14-0954","article-title":"Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys","volume":"162","author":"Mdodo","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2018.11.029_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1513\/pats.201009-058WR","article-title":"Cigarette smoking in the HIV-infected population","volume":"8","author":"Rahmanian","year":"2011","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.cjca.2018.11.029_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/09540121.2015.1099602","article-title":"Coronary artery disease risk reduction in HIV-infected persons: a comparative analysis","volume":"28","author":"Okeke","year":"2016","journal-title":"AIDS Care"},{"key":"10.1016\/j.cjca.2018.11.029_bib19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(05)79053-X","article-title":"Severe premature coronary artery disease with protease inhibitors","volume":"351","author":"Henry","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2018.11.029_bib20","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(98)26026-0","article-title":"Vascular complications associated with use of HIV protease inhibitors","volume":"351","author":"Behrens","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2018.11.029_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/088922203766774487","article-title":"Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors","volume":"19","author":"Coplan","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.cjca.2018.11.029_bib22","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.11.029_bib23","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.11.029_bib24","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/eht388","article-title":"HIV and the heart: the impact of antiretroviral therapy: a global perspective","volume":"34","author":"Thienemann","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.11.029_bib25","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archinternmed.2010.197","article-title":"Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4","volume":"170","author":"Lang","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2018.11.029_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.11.029_bib27","volume":"6","author":"Baker","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2018.11.029_bib28","doi-asserted-by":"crossref","first-page":"e44454","DOI":"10.1371\/journal.pone.0044454","article-title":"Inflammation, coagulation and cardiovascular disease in HIV-infected individuals","volume":"7","author":"Duprez","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2018.11.029_bib29","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0140-6736(92)92270-P","article-title":"Coronary lesions in young HIV-positive subjects at necropsy","volume":"340","author":"Tabib","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2018.11.029_bib30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/M13-1754","article-title":"Associations between HIV infection and subclinical coronary atherosclerosis","volume":"160","author":"Post","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2018.11.029_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/QAD.0b013e328333ea9e","article-title":"Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men","volume":"24","author":"Lo","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.cjca.2018.11.029_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehq372","article-title":"Prognosis of Acute Coronary Syndrome in HIV-infected patients (PACS) Investigators. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis","volume":"32","author":"Boccara","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.11.029_bib33","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/QAD.0b013e32835eca9b","article-title":"Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men","volume":"27","author":"Zanni","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.cjca.2018.11.029_bib34","doi-asserted-by":"crossref","first-page":"e000511","DOI":"10.1136\/openhrt-2016-000511","article-title":"Lower coronary plaque burden in patients with HIV presenting with acute coronary syndrome","volume":"3","author":"O'Dwyer","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.cjca.2018.11.029_bib35","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/infdis\/jix082","article-title":"Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-infected women and men","volume":"215","author":"Hanna","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cjca.2018.11.029_bib36","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.jacc.2017.05.012","article-title":"HIV-1-associated atherosclerosis: unraveling the missing link","volume":"69","author":"Kearns","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.11.029_bib37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOL.0000000000000440","article-title":"Mechanisms of erosion of atherosclerotic plaques","volume":"28","author":"Quillard","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2018.11.029_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fimmu.2017.00081","article-title":"Neutrophil extracellular traps and its implications in inflammation: an overview","volume":"8","author":"Delgado-Rizo","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.cjca.2018.11.029_bib39","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehv044","article-title":"TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion","volume":"36","author":"Quillard","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.11.029_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCRESAHA.117.310694","article-title":"Flow perturbation mediates neutrophil recruitment and potentiates endothelial injury via TLR2 in mice: implications for superficial erosion","volume":"121","author":"Franck","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2018.11.029_bib41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fimmu.2015.00426","article-title":"HIV-1 structural proteins serve as PAMPs for TLR2 heterodimers significantly increasing infection and innate immune activation","volume":"6","author":"Henrick","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.cjca.2018.11.029_bib42","doi-asserted-by":"crossref","first-page":"e000174","DOI":"10.1136\/openhrt-2014-000174","article-title":"Cardiovascular disease in HIV patients: from bench to bedside and backwards","volume":"2","author":"Cerrato","year":"2015","journal-title":"Open Heart"},{"key":"10.1016\/j.cjca.2018.11.029_bib43","first-page":"223","article-title":"Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages","volume":"14","author":"Lopez","year":"2012","journal-title":"AIDS Rev"},{"key":"10.1016\/j.cjca.2018.11.029_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1540-8183.2009.00520.x","article-title":"Acute coronary syndromes in treatment-naive black South Africans with human immunodeficiency virus infection","volume":"23","author":"Becker","year":"2010","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.cjca.2018.11.029_bib45","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/eurheartj\/ehr398","article-title":"Contribution of the human immunodeficiency virus\/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort","volume":"33","author":"Sliwa","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.11.029_bib46","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.11.029_bib47","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/eurheartj\/ehl501","article-title":"Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?","volume":"28","author":"Lerman","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.11.029_bib48","article-title":"Role of T-cell dysfunction, inflammation, and coagulation in microvascular disease in HIV","volume":"5","author":"Sinha","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2018.11.029_bib49","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.0000114520.38748.AA","article-title":"Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.11.029_bib50","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurheartj\/ehr456","article-title":"Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy","volume":"33","author":"D'Ascenzo","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.11.029_bib51","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2018.05.001","article-title":"Evaluation of coronary features of HIV patients presenting with ACS: The CUORE, a multicenter study","volume":"274","author":"Peyracchia","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2018.11.029_bib52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.thromres.2014.05.037","article-title":"Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States","volume":"134","author":"D'Ascenzo","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2018.11.029_bib53","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamacardio.2016.5139","article-title":"Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Cohort. Types of Myocardial infarction among human immunodeficiency virus-infected individuals in the United States","volume":"2","author":"Crane","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2018.11.029_bib54","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.amjcard.2009.03.036","article-title":"Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection","volume":"104","author":"Ren","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2018.11.029_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/157016208783571900","article-title":"French Italian Study on Coronary Artery Disease in AIDS Patients (FRISCA-2). Coronary artery bypass graft in HIV-infected patients: a multicenter case control study","volume":"6","author":"Boccara","year":"2008","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.cjca.2018.11.029_bib56","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.jacc.2016.07.771","article-title":"HIV-related myocardial vulnerability to infarction and coronary artery disease","volume":"68","author":"Feinstein","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.11.029_bib57","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s12350-016-0689-7","article-title":"Differences by HIV serostatus in coronary artery disease severity and likelihood of percutaneous coronary intervention following stress testing","volume":"25","author":"Feinstein","year":"2018","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.cjca.2018.11.029_bib58","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cit665","article-title":"Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America","volume":"58","author":"Aberg","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cjca.2018.11.029_bib59","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.amjcard.2015.03.025","article-title":"A\u00a0systematic review of the usefulness of statin therapy in HIV-infected patients","volume":"115","author":"Feinstein","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2018.11.029_bib60","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/1060028014523115","article-title":"Drug interactions between antiplatelet or novel oral anticoagulant medications and antiretroviral medications","volume":"48","author":"Egan","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cjca.2018.11.029_bib61","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/QAD.0b013e328339192f","article-title":"French Hospital Database on HIV-ANRS CO4. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population","volume":"24","author":"Lang","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.cjca.2018.11.029_bib62","doi-asserted-by":"crossref","first-page":"e001035","DOI":"10.1161\/JAHA.114.001035","article-title":"HIV infection and cardiovascular disease in women","volume":"3","author":"Womack","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2018.11.029_bib63","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/infdis\/jit508","article-title":"Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women","volume":"208","author":"Fitch","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cjca.2018.11.029_bib64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijcard.2017.02.117","article-title":"Cardiovascular disease in women with HIV-1 infection","volume":"241","author":"Volpe","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2018.11.029_bib65","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/heartjnl-2016-309752","article-title":"Cardiovascular disease risk assessment in HIV: navigating data-sparse zones","volume":"102","author":"Feinstein","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2018.11.029_bib66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamacardio.2016.4494","article-title":"Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus: a study by the Centers for AIDS Research Network of Integrated Clinical Systems","volume":"2","author":"Feinstein","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2018.11.029_bib67","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/CIRCULATIONAHA.117.028975","article-title":"Cardiovascular risk prediction functions underestimate risk in HIV infection","volume":"137","author":"Triant","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.11.029_bib68","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/2047487315579291","article-title":"An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study","volume":"23","author":"Friis-Moller","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cjca.2018.11.029_bib69","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2352-3018(14)00032-0","article-title":"Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial","volume":"2","author":"Lo","year":"2015","journal-title":"Lancet HIV"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X18313199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X18313199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:40:41Z","timestamp":1760107241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X18313199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0828282X18313199"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2018.11.029","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary Artery Disease Manifestations in HIV: What, How, and Why","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2018.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}